DE Burlo Group Inc. acquired a new position in Cantel Medical Corp. (NYSE:CMD) during the second quarter, Holdings Channel reports. The institutional investor acquired 10,800 shares of the company’s stock, valued at approximately $841,000.

A number of other institutional investors have also added to or reduced their stakes in CMD. Integrated Investment Consultants LLC acquired a new position in Cantel Medical Corp. during the second quarter worth approximately $161,000. LS Investment Advisors LLC acquired a new position in Cantel Medical Corp. during the second quarter worth approximately $172,000. SG Americas Securities LLC acquired a new position in Cantel Medical Corp. during the second quarter worth approximately $230,000. First Quadrant L P CA acquired a new position in Cantel Medical Corp. during the second quarter worth approximately $233,000. Finally, Cue Financial Group Inc. acquired a new position in Cantel Medical Corp. during the second quarter worth approximately $234,000. 83.66% of the stock is owned by hedge funds and other institutional investors.

Cantel Medical Corp. (CMD) opened at 75.49 on Friday. Cantel Medical Corp. has a one year low of $68.19 and a one year high of $88.81. The stock’s 50 day moving average is $75.69 and its 200 day moving average is $76.81. The firm has a market cap of $3.13 billion, a P/E ratio of 44.67 and a beta of 1.23.

Cantel Medical Corp. (NYSE:CMD) last announced its earnings results on Thursday, June 8th. The company reported $0.51 EPS for the quarter, hitting the consensus estimate of $0.51. The company had revenue of $192.10 million for the quarter, compared to analysts’ expectations of $193.84 million. Cantel Medical Corp. had a return on equity of 17.75% and a net margin of 9.50%. The company’s revenue was up 10.6% compared to the same quarter last year. On average, equities research analysts expect that Cantel Medical Corp. will post $2.06 earnings per share for the current year.

The firm also recently announced a semiannual dividend, which was paid on Monday, July 31st. Stockholders of record on Monday, July 17th were issued a dividend of $0.07 per share. This represents a dividend yield of 0.18%. The ex-dividend date was Thursday, July 13th. Cantel Medical Corp.’s payout ratio is presently 8.28%.

WARNING: This report was first posted by Watch List News and is owned by of Watch List News. If you are reading this report on another website, it was copied illegally and reposted in violation of US & international copyright and trademark law. The original version of this report can be accessed at https://www.watchlistnews.com/de-burlo-group-inc-takes-position-in-cantel-medical-corp-cmd/1503027.html.

A number of equities analysts have commented on the stock. Zacks Investment Research downgraded shares of Cantel Medical Corp. from a “hold” rating to a “sell” rating in a report on Monday, June 5th. Benchmark Co. downgraded shares of Cantel Medical Corp. from a “buy” rating to a “hold” rating in a report on Friday, June 9th. Needham & Company LLC reaffirmed a “hold” rating on shares of Cantel Medical Corp. in a report on Thursday, June 8th. Finally, Sidoti raised shares of Cantel Medical Corp. from a “neutral” rating to a “buy” rating and set a $92.00 price objective for the company in a report on Wednesday, August 2nd. Four investment analysts have rated the stock with a hold rating and one has assigned a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and a consensus target price of $91.67.

In related news, Chairman Charles M. Diker sold 35,000 shares of the firm’s stock in a transaction dated Wednesday, July 12th. The stock was sold at an average price of $75.52, for a total value of $2,643,200.00. Following the transaction, the chairman now owns 3,114,520 shares in the company, valued at $235,208,550.40. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Chairman Charles M. Diker sold 13,000 shares of the firm’s stock in a transaction dated Monday, June 12th. The shares were sold at an average price of $76.36, for a total value of $992,680.00. Following the completion of the transaction, the chairman now owns 3,124,222 shares in the company, valued at approximately $238,565,591.92. The disclosure for this sale can be found here. 14.90% of the stock is currently owned by corporate insiders.

Cantel Medical Corp. Company Profile

Cantel Medical Corp. is a provider of infection prevention products and services in the healthcare market. The Company’s operating segments include Endoscopy; Water Purification and Filtration; Healthcare Disposables, and Dialysis. Its Endoscopy segment includes medical device reprocessing systems, disinfectants, detergents and other supplies.

Want to see what other hedge funds are holding CMD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cantel Medical Corp. (NYSE:CMD).

Institutional Ownership by Quarter for Cantel Medical Corp. (NYSE:CMD)

Receive News & Ratings for Cantel Medical Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cantel Medical Corp. and related companies with Analyst Ratings Network's FREE daily email newsletter.